Pharma Journalist -

Zura Bio Limited (“Zura Bio”), a clinical-stage biotechnology company focused on developing novel medicines for immune disorders, and JATT Acquisition Corp., a publicly traded special…
Read More...

Hansa Biopharma, "Hansa" announces the recommendation by the National Institute for Health and Care Excellence (NICE) for its first-in-class treatment Idefirix in the desensitization of…
Read More...

Exelixis, Inc. and BioInvent International AB announced that the companies have entered into an option and license agreement focused on the identification and development of novel…
Read More...

Panbela Therapeutics, Inc. a clinical stage company developing disruptive therapeutics for the treatment of patients with cancer, announced the closing of its acquisition of Cancer…
Read More...

Humanigen, Inc. announced it entered into an agreement with PCI Pharma Services (PCI), a leading integrated global contract development manufacturing organization (CDMO), to provide…
Read More...

Jazz Pharmaceuticals and Redx announce the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for JZP815, a pan-RAF inhibitor for the…
Read More...

EMA has started a rolling review for a version of Comirnaty adapted to provide better protection against a specific variant or variants of SARS-CoV-2, the virus that causes COVID-19.…
Read More...

Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, and French pharmaceutical group Pierre Fabre announced that the companies have…
Read More...

Kintara Therapeutics, Inc. announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation (FTD) to Kintara's VAL-083 for the treatment of…
Read More...

Researchers from the University of Sheffield and Stanford University in the US have discovered there are specific genetic signals in people who develop severe coronavirus infection.…
Read More...